Published in Cardiovascular Business Week, February 5th, 2008
The first patient found suitable for inclusion in the STABLE dissection clinical trial was a 60-year-old male diagnosed with a Type B...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.